STOCK TITAN

APLMW Schedule 13D: Hung-Wen Chen, King Regent Disclose 41.8% Stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D

Rhea-AI Filing Summary

Apollomics Inc. disclosed on a Schedule 13D that Hung-Wen (Howard) Chen and his wholly owned vehicle, King Regent Management Limited, together hold 896,362 Class A ordinary shares, representing 41.8% of the issuer's outstanding Class A shares (2,146,151 shares outstanding as disclosed). The holdings comprise 133,334 shares directly held by Mr. Chen and 763,028 shares held by King Regent. The filing amends a prior Schedule 13G and notes that Mr. Chen is Chairman and CEO; King Regent is a private investment holding company wholly owned by him. The transaction source is identified as PIPE subscription agreements executed on September 2, 2025, and the filing includes a joint filing agreement as an exhibit.

Positive

  • Material disclosure of ownership: The filing clearly states aggregate beneficial ownership of 896,362 shares (41.8%).
  • Transparency on relationships: The filing discloses that King Regent is wholly owned by Hung-Wen Chen and includes a joint filing agreement exhibit.
  • Update to prior filing: This Schedule 13D amends the earlier Schedule 13G, providing current ownership following the PIPE subscription agreements.

Negative

  • High insider concentration: Combined holdings of the CEO and his vehicle represent a 41.8% stake, centralizing voting power.
  • Potential liquidity impact: A large insider stake may reduce freely tradable float for Class A ordinary shares.

Insights

TL;DR: A controlling-sized 41.8% position was disclosed via a PIPE-related ownership by the company CEO and his vehicle.

The disclosed 41.8% aggregate position is material to investors because it signals that a single insider and his affiliated entity collectively hold a near-majority stake of outstanding Class A shares. The split shows both direct ownership (133,334 shares) and concentrated ownership through King Regent (763,028 shares). This level of insider ownership can affect liquidity, vote outcomes, and control dynamics. The filing updates a prior Schedule 13G and documents the PIPE subscription agreements as the transactional basis.

TL;DR: Significant insider concentration from CEO and affiliated entity raises governance and control considerations.

A 41.8% holding by the CEO and his wholly owned investment vehicle is governance-relevant: it centralizes voting power and may influence board and shareholder decisions. The Schedule 13D discloses the relationship (Mr. Chen owns and directs King Regent) and the nature of the acquisition






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Hung-Wen Chen
Signature:/s/ Hung-Wen Chen
Name/Title:Hung-Wen Chen, Director
Date:09/09/2025
King Regent Management Limited
Signature:/s/ Hung-Wen Chen
Name/Title:Hung-Wen Chen, Director
Date:09/09/2025

FAQ

What stake does Hung-Wen (Howard) Chen and King Regent hold in Apollomics (APLMW)?

They beneficially own 896,362 Class A shares, representing 41.8% of the outstanding Class A shares (2,146,151 total).

How are the 896,362 shares split between Mr. Chen and King Regent?

Mr. Chen holds 133,334 shares directly and King Regent holds 763,028 shares.

What transaction led to the Schedule 13D filing for APLMW?

The filing reports ownership related to PIPE subscription agreements entered into on September 2, 2025, as disclosed in the issuer's Form 6-K.

Does the filing indicate any legal proceedings or disclosable events?

No; Items 2(d) and 2(e) indicate No for required disclosure of legal proceedings in the provided content.

Who signed the Schedule 13D for Apollomics?

The statement is signed by Hung-Wen Chen in his capacity as Director on behalf of both himself and King Regent Management Limited.
APOLLOMICS INC

NASDAQ:APLMW

APLMW Rankings

APLMW Latest News

APLMW Latest SEC Filings

APLMW Stock Data

1.32M
1.10M